Vasopressin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Vasopressin.
| Product ID | 0517-1020_33d0aa3c-6304-4198-bb7e-523eb1572fef |
| NDC | 0517-1020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vasopressin |
| Generic Name | Vasopressin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-02-03 |
| Marketing Category | NDA / |
| Application Number | NDA212593 |
| Labeler Name | American Regent, Inc. |
| Substance Name | VASOPRESSIN |
| Active Ingredient Strength | 20 [USP'U]/mL |
| Pharm Classes | Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-02-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-10-01 |
| Marketing End Date | 2013-06-01 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0517-1020 | Vasopressin | Vasopressin |
| 0548-9701 | Vasopressin | Vasopressin |
| 42367-570 | VASOPRESSIN | VASOPRESSIN |
| 43598-085 | Vasopressin | Vasopressin |
| 51662-1314 | VASOPRESSIN | VASOPRESSIN |
| 51662-1607 | VASOPRESSIN | VASOPRESSIN |
| 52584-302 | VASOPRESSIN | vasopressin |
| 55150-370 | VASOPRESSIN | VASOPRESSIN |
| 55150-371 | Vasopressin | Vasopressin |
| 63323-302 | Vasopressin | VASOPRESSIN |
| 70121-1642 | vasopressin | vasopressin |
| 42023-164 | Vasostrict | Vasopressin |
| 42023-190 | Vasostrict | Vasopressin |
| 42023-219 | Vasostrict | Vasopressin |
| 42023-220 | Vasostrict | Vasopressin |
| 42023-237 | Vasostrict | Vasopressin |